Dumulon-Perreault V - Search Results

1

Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.

Ait-Mohand S, Fournier P, Dumulon-Perreault V, Kiefer GE, Jurek P, Ferreira CL, Bénard F, Guérin B. Ait-Mohand S, et al. Bioconjug Chem. 2011 Aug 17;22(8):1729-35. doi: 10.1021/bc2002665. Epub 2011 Jul 29. Bioconjug Chem. 2011. PMID: 21761921

2

Total solid-phase synthesis of NOTA-functionalized peptides for PET imaging.

Guérin B, Ait-Mohand S, Tremblay MC, Dumulon-Perreault V, Fournier P, Bénard F. Guérin B, et al. Org Lett. 2010 Jan 15;12(2):280-3. doi: 10.1021/ol902601x. Org Lett. 2010. PMID: 20014826

3

[Lys(DOTA)4]BVD15, a novel and potent neuropeptide Y analog designed for Y1 receptor-targeted breast tumor imaging.

Guérin B, Dumulon-Perreault V, Tremblay MC, Ait-Mohand S, Fournier P, Dubuc C, Authier S, Bénard F. Guérin B, et al. Bioorg Med Chem Lett. 2010 Feb 1;20(3):950-3. doi: 10.1016/j.bmcl.2009.12.068. Epub 2009 Dec 23. Bioorg Med Chem Lett. 2010. PMID: 20042335

4

Comparative study of 64Cu/NOTA-[D-Tyr6,βAla11,Thi13,Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imaging.

Fournier P, Dumulon-Perreault V, Ait-Mohand S, Langlois R, Bénard F, Lecomte R, Guérin B. Fournier P, et al. EJNMMI Res. 2012 Feb 14;2:8. doi: 10.1186/2191-219X-2-8. EJNMMI Res. 2012. PMID: 22333272 Free PMC article.

5

Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).

Fournier P, Dumulon-Perreault V, Ait-Mohand S, Tremblay S, Bénard F, Lecomte R, Guérin B. Fournier P, et al. Bioconjug Chem. 2012 Aug 15;23(8):1687-93. doi: 10.1021/bc3002437. Epub 2012 Jul 25. Bioconjug Chem. 2012. PMID: 22770480

6

[(11)C]-Acetoacetate PET imaging: a potential early marker for cardiac heart failure.

Croteau E, Tremblay S, Gascon S, Dumulon-Perreault V, Labbé SM, Rousseau JA, Cunnane SC, Carpentier AC, Bénard F, Lecomte R. Croteau E, et al. Among authors: dumulon perreault v. Nucl Med Biol. 2014 Nov-Dec;41(10):863-70. doi: 10.1016/j.nucmedbio.2014.08.006. Epub 2014 Aug 13. Nucl Med Biol. 2014. PMID: 25195015

7

PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.

Couture F, Levesque C, Dumulon-Perreault V, Ait-Mohand S, D'Anjou F, Day R, Guérin B. Couture F, et al. Among authors: dumulon perreault v. Neoplasia. 2014 Aug;16(8):634-43. doi: 10.1016/j.neo.2014.07.010. Neoplasia. 2014. PMID: 25220591 Free PMC article.

8

Impact of dianionic and dicationic linkers on tumor uptake and biodistribution of [⁶⁴ Cu]Cu/NOTA peptide-based gastrin-releasing peptide receptors antagonists.

Mansour N, Dumulon-Perreault V, Ait-Mohand S, Paquette M, Lecomte R, Guérin B. Mansour N, et al. Among authors: dumulon perreault v. J Labelled Comp Radiopharm. 2017 Apr;60(4):200-212. doi: 10.1002/jlcr.3491. Epub 2017 Mar 5. J Labelled Comp Radiopharm. 2017. PMID: 28129446

9

Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [⁶⁴Cu]-DOTHA₂-PEG-RM26.

Mansour N, Paquette M, Ait-Mohand S, Dumulon-Perreault V, Guérin B. Mansour N, et al. Among authors: dumulon perreault v. Nucl Med Biol. 2018 Jan;56:31-38. doi: 10.1016/j.nucmedbio.2017.10.006. Epub 2017 Oct 23. Nucl Med Biol. 2018. PMID: 29154145

10

Promising Performance of 4HMS, a New Zirconium-89 Octadendate Chelator.

Alnahwi AH, Ait-Mohand S, Dumulon-Perreault V, Dory YL, Guérin B. Alnahwi AH, et al. Among authors: dumulon perreault v. ACS Omega. 2020 May 5;5(19):10731-10739. doi: 10.1021/acsomega.0c00207. eCollection 2020 May 19. ACS Omega. 2020. PMID: 32455192 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page